Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy bluebird bio (BLUE) stock
Learn how to easily invest in bluebird bio stock.
bluebird bio, Inc is a biotechnology business based in the US. bluebird bio shares (BLUE) are listed on the NASDAQ and all prices are listed in US Dollars. bluebird bio employs 1,201 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in bluebird bio
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BLUE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
bluebird bio stock price (NASDAQ: BLUE)Use our graph to track the performance of BLUE stocks over time.
bluebird bio shares at a glance
|Latest market close||$31.12|
|52-week range||$24.24 - $68.39|
|50-day moving average||$31.08|
|200-day moving average||$33.73|
|Wall St. target price||$46.93|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-12.00|
Buy bluebird bio shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy bluebird bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
bluebird bio price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-0.16%|
|3 months (2021-04-28)||2.40%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Is bluebird bio under- or over-valued?
Valuing bluebird bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of bluebird bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
bluebird bio's PEG ratio
bluebird bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into bluebird bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
bluebird bio financials
|Revenue TTM||$241.7 million|
|Gross profit TTM||$-342,618,000|
|Return on assets TTM||-25.81%|
|Return on equity TTM||-53.59%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
Shorting bluebird bio shares
There are currently 6.3 million bluebird bio shares held short by investors – that's known as bluebird bio's "short interest". This figure is 18.4% up from 5.3 million last month.
There are a few different ways that this level of interest in shorting bluebird bio shares can be evaluated.
bluebird bio's "short interest ratio" (SIR)
bluebird bio's "short interest ratio" (SIR) is the quantity of bluebird bio shares currently shorted divided by the average quantity of bluebird bio shares traded daily (recently around 1.9 million). bluebird bio's SIR currently stands at 3.32. In other words for every 100,000 bluebird bio shares traded daily on the market, roughly 3320 shares are currently held short.
However bluebird bio's short interest can also be evaluated against the total number of bluebird bio shares, or, against the total number of tradable bluebird bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case bluebird bio's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 bluebird bio shares in existence, roughly 90 shares are currently held short) or 0.0949% of the tradable shares (for every 100,000 tradable bluebird bio shares, roughly 95 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against bluebird bio.
Find out more about how you can short bluebird bio stock.
bluebird bio share dividends
We're not expecting bluebird bio to pay a dividend over the next 12 months.
bluebird bio share price volatility
Over the last 12 months, bluebird bio's shares have ranged in value from as little as $24.24 up to $68.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while bluebird bio's is 1.7394. This would suggest that bluebird bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
bluebird bio overview
bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's product candidates in oncology include Idecabtagene vicleucel and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has collaboration and license agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc. , Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc. , Gritstone Oncology, Inc.
Stocks similar to bluebird bio
bluebird bio in the news
BLUEBIRD BIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of bluebird bio, Inc. - BLUE
bluebird bio Receives EC Approval for SKYSONA™ (elivaldogene autotemcel, Lenti-D™) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor
bluebird bio (NASDAQ:BLUE) Is In A Good Position To Deliver On Growth Plans
Frequently asked questionsWhat percentage of bluebird bio is owned by insiders or institutions?
Currently 0.894% of bluebird bio shares are held by insiders and 79.665% by institutions. How many people work for bluebird bio?
Latest data suggests 1,201 work at bluebird bio. When does the fiscal year end for bluebird bio?
bluebird bio's fiscal year ends in December. Where is bluebird bio based?
bluebird bio's address is: 60 Binney Street, Cambridge, MA, United States, 02142 What is bluebird bio's ISIN number?
bluebird bio's international securities identification number is: US09609G1004 What is bluebird bio's CUSIP number?
bluebird bio's Committee on Uniform Securities Identification Procedures number is: 09609G100
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert